890652-00-3

Basic information

• Product Name: AKOS BC-0115
• Synonyms: AKOS BC-0115;3-[2-(4-METHYL-PIPERAZIN-1-YL)-ETHOXY]-PHENYLAMINE;3-[2-(4-methyl-1-piperazinyl)ethoxy]benzenamine
• CAS NO: 890652-00-3
• Molecular Formula: C₁₃H₂₁N₃O
• Molecular Weight: 235.33
• Mol File: 890652-00-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: AKOS BC-0115(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS BC-0115(890652-00-3)
• EPA Substance Registry System: AKOS BC-0115(890652-00-3)

Safety Data

• Hazardous Substances Data: 890652-00-3(Hazardous Substances Data)

Upstream product

• 109-01-3 1-methyl-piperazine 
• 87291-34-7 1-(2-chloroethoxy)-3-nitrobenzene 
• 554-84-7 meta-nitrophenol 
• 13831-59-9 2-(3-nitrophenoxy)bromoethane 
• 891856-25-0 1-methyl-4-(2-(3-nitrophenoxy)ethyl)piperazine 

Downstream Products

• 1254951-08-0 1-adamantan-1-yl-3-(3-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)urea 

Relevant articles and documents

2-Aminophenylpyrimidines as Novel Inhibitors of Aminoacyl-tRNA Synthetase Interacting Multifunctional Protein 2 (AIMP2)-DX2 for Lung Cancer Treatment

Aminoacyl-tRNA synthetase interacting multifunctional proteins (AIMPs) have recently been considered novel therapeutic targets in several cancers. In this publication we report the development of novel 2-aminophenylpyrimidines as new AIMP2-DX2 inhibitors.

Piperazine substituted 1, 3 - di-substituted urea compound and piperazine substituted amide compounds and a method for its preparation and use

The present invention relates to a class of piperazine substituted 1,3-disubstitued urea compounds and piperazine substituted amide compounds, or pharmaceutically acceptable salts of the piperazine substituted 1,3-disubstitued urea compounds and the piper

Incorporation of piperazino functionality into 1,3-disubstituted urea as the tertiary pharmacophore affording potent inhibitors of soluble epoxide hydrolase with improved pharmacokinetic properties

The inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of hypertension, inflammation, and other disorders. However, the problems of limited water solubility, high melting point, and low metabolic stabil

Pyrrolopyrimidine Compounds and Their Uses

The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrrolopyrimidine compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease.